Oscar Health (NYSE:OSCR) Sets New 1-Year High at $18.69

Oscar Health, Inc. (NYSE:OSCR)’s share price reached a new 52-week high during trading on Friday . The stock traded as high as $18.69 and last traded at $18.12, with a volume of 509291 shares changing hands. The stock had previously closed at $18.09.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Raymond James began coverage on Oscar Health in a research note on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target for the company. TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a research report on Wednesday, February 21st. The Goldman Sachs Group increased their price objective on Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a research report on Friday, February 9th. Finally, Wells Fargo & Company boosted their target price on Oscar Health from $12.00 to $20.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $13.50.

Oscar Health Price Performance

The business’s fifty day moving average price is $15.30 and its 200-day moving average price is $11.67. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $4.14 billion, a P/E ratio of -15.02 and a beta of 1.66.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.74) by $0.08. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The company’s revenue for the quarter was up 43.9% compared to the same quarter last year. During the same period in the prior year, the business earned ($1.05) EPS. As a group, sell-side analysts predict that Oscar Health, Inc. will post -0.23 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Several institutional investors and hedge funds have recently made changes to their positions in OSCR. Prevail Innovative Wealth Advisors LLC purchased a new stake in Oscar Health during the 4th quarter valued at about $92,000. Precision Wealth Strategies LLC purchased a new stake in Oscar Health during the 3rd quarter valued at $60,000. SG Americas Securities LLC bought a new stake in shares of Oscar Health in the third quarter worth about $62,000. Cornerstone Investment Partners LLC purchased a new stake in Oscar Health in the 1st quarter worth approximately $178,000. Finally, Handelsbanken Fonder AB bought a new stake in shares of Oscar Health in the 4th quarter worth approximately $110,000. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.